Is Prelude Therapeutics, Inc. PRLD stock halal to invest in?

No, as of February 2026, Prelude Therapeutics, Inc. stock (PRLD) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Prelude Therapeutics, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Prelude Therapeutics, Inc. and alternative halal stock options within the Tabadulat app.

How often is Prelude Therapeutics, Inc. PRLD reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Prelude Therapeutics, Inc. PRLD monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Prelude Therapeutics, Inc. PRLD pass the AAOIFI Non Permissible Income criteria?

Yes, as of February 2026, Prelude Therapeutics, Inc. stock (PRLD) passes the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources, such as interest, is below the acceptable threshold set by AAOIFI.

Does Prelude Therapeutics, Inc. PRLD pass the AAOIFI Interest Bearing Investments criteria?

No, as of February 2026, Prelude Therapeutics, Inc. stock (PRLD) does not pass the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments have exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Prelude Therapeutics, Inc. stock (PRLD) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Prelude Therapeutics, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

PRLD

About

Prelude Therapeutics, Inc.

PRLD

Prelude Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies targeting cancer. Its primary function is to advance the understanding of molecular diseases and design precision therapies aimed at challenging hematologic malignancies and solid tumors. The company's research is deeply rooted in understanding the intricate biological pathways driving cancer, which allows them to identify novel targets for drug development. Prelude's pipeline consists of a range of compounds in various phases of development, each tailored to inhibit specific cancer-causing proteins and pathways. Operating predominantly in the biopharmaceutical and healthcare sectors, Prelude Therapeutics impacts both the scientific community and the pharmaceutical industry by contributing to the advancement of targeted cancer therapies. The company plays a significant role in the ongoing evolution of precision medicine, striving to offer more personalized and effective treatment options that can potentially improve outcomes and quality of life for patients battling cancer.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

131

Website:

https://preludetx.com

PRLD

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Prelude Therapeutics, Inc.

About

Prelude Therapeutics, Inc.

PRLD

Frequently asked questions

Is Prelude Therapeutics, Inc. PRLD stock halal to invest in?

How often is Prelude Therapeutics, Inc. PRLD reviewed for Shariah compliance?

Does Prelude Therapeutics, Inc. PRLD pass the AAOIFI Non Permissible Income criteria?

Does Prelude Therapeutics, Inc. PRLD pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Prelude Therapeutics, Inc. PRLD stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.